Explain this page
Arphra AIPlain-English read on Chimera Investment Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +100.00% | +100.00% | +100.00% | +100.00% | +94.87% | +100.62% | +101.09% | +97.75% |
| Operating margin | 0.00% | 0.00% | 0.00% | 0.00% | +93.16% | +31.17% | +30.34% | +31.31% |
| EBITDA margin | 0.00% | 0.00% | 0.00% | 0.00% | +96.84% | +32.22% | +32.05% | +33.02% |
| EBIT margin | 0.00% | 0.00% | 0.00% | 0.00% | +95.97% | +32.74% | +31.37% | +31.95% |
| Pre-tax margin | +63.81% | +123.63% | +61.63% | +68.28% | +28.36% | +51.27% | +53.41% | +51.57% |
| Net margin | +63.40% | +123.57% | +61.58% | +68.26% | +28.08% | +31.75% | +31.57% | +31.66% |
| Cost structure | ||||||||
| Cost of revenue / sales | 0.00% | 0.00% | 0.00% | 0.00% | +5.13% | +1.74% | +1.75% | +1.72% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +6.53% | -17.35% | +27.20% | +25.03% | +3.65% | +18.95% | +18.16% | +18.21% |
| Effective tax rate | +0.65% | — | +0.08% | +0.03% | +0.97% | +0.37% | +0.35% | +0.38% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +17.94% | -19.24% | +4.93% | +6.97% | +8.96% | +3.97% | +3.89% | +3.98% |
| Return on assets (ROA) | +4.35% | -3.83% | +0.98% | +1.34% | +1.46% | +0.73% | +0.69% | +0.71% |
| Return on capital (ROC) | 0.00% | 0.00% | 0.00% | 0.00% | +4.89% | +0.72% | +0.71% | +0.74% |
| Return on invested capital (ROIC) | 0.00% | 0.00% | 0.00% | 0.00% | +1.47% | +0.73% | +0.74% | +0.75% |
| Asset turnover | +6.86% | -3.10% | +1.58% | +1.97% | +5.19% | +2.31% | +2.19% | +2.25% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +63.40% | +123.57% | +61.58% | +68.26% | +28.08% | +31.75% | +31.57% | +31.66% |
| Asset turnover (× revenue / assets) | +6.86% | -3.10% | +1.58% | +1.97% | +5.19% | +2.31% | +2.19% | +2.25% |
| Equity multiplier (× assets / equity) | +412.38% | +502.55% | +505.25% | +519.22% | +614.47% | +541.23% | +563.79% | +559.36% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.07 | -0.03 | 0.02 | 0.02 | 0.05 | 0.02 | 0.02 | 0.02 |
| Fixed-asset turnover | — | — | — | — | — | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 0.09 | -0.04 | 0.02 | 0.02 | 7.08 | — | — | — |
| Payables turnover | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 4234.12 | -9985.60 | 20315.29 | 15844.62 | 51.58 | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | — | — | — | — | — | — | — | — |
| Cash conversion cycle | — | — | — | — | 51.58 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 0.77 | -0.63 | 1.69 | 1.17 | -1.08 | 1.58 | 1.59 | 1.59 |
| FCF / Net income | 0.77 | -0.63 | 1.69 | 1.17 | -1.08 | 1.63 | 1.62 | 1.66 |
| FCF margin | +49.12% | -78.45% | +104.15% | +79.74% | -30.32% | +51.76% | +51.29% | +52.63% |
| OCF margin | +49.12% | -78.45% | +104.15% | +79.74% | -30.32% | +50.10% | +50.20% | +50.47% |
| CapEx / Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| CapEx / D&A | 0.00 | 0.00 | — | 0.00 | 0.00 | — | — | — |
| Stock-based comp / Revenue | +0.62% | -1.97% | +4.66% | +3.91% | +6.91% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 2.43 | -2.19 | 0.54 | 1.10 | 2.75 | 2.20 | 2.29 | 2.30 |
| EPS · basic | 7.65 | -2.19 | 0.55 | 1.12 | 2.80 | 2.24 | 2.30 | 2.37 |
| Book value / share | 45.66 | 34.20 | 32.75 | 30.75 | 30.65 | 39.53 | 39.72 | 38.59 |
| Tangible BV / share | 45.66 | 34.20 | 32.75 | 30.75 | 30.65 | 39.53 | 39.72 | 38.59 |
| Sales / share | 12.92 | -5.32 | 2.62 | 3.14 | 9.78 | 4.95 | 4.90 | 4.85 |
| Operating CF / share | 6.34 | 4.18 | 2.73 | 2.50 | -2.96 | 2.48 | 2.46 | 2.45 |
| Free cash flow / share | 6.34 | 4.18 | 2.73 | 2.50 | -2.96 | 2.56 | 2.51 | 2.55 |
| Dividends / share | 3.65 | 3.69 | 2.50 | 1.45 | 1.02 | 2.49 | 2.45 | 2.52 |
| Payout ratio | +44.57% | -56.08% | +154.81% | +67.63% | +37.32% | +158.67% | +158.03% | +164.44% |
| Retention ratio | +55.43% | +156.08% | -54.81% | +32.37% | +62.68% | -58.67% | -58.03% | -64.44% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | -139.28% | +149.32% | +25.96% | +218.22% | -49.71% | +0.47% | -1.86% | -12.74% |
| Gross profit · YoY | — | -139.28% | +149.32% | +25.96% | +201.89% | -46.66% | +0.93% | -5.10% | -13.03% |
| Profit | |||||||||
| Operating income · YoY | — | — | — | — | — | -83.17% | -2.19% | +1.28% | — |
| EBITDA · YoY | — | — | — | — | — | -83.27% | -0.07% | +1.13% | — |
| Net income · YoY | — | -176.56% | +124.58% | +39.62% | +30.92% | -43.14% | -0.09% | -1.57% | -20.98% |
| Operating | |||||||||
| EBIT · YoY | — | — | — | — | — | -82.84% | -3.74% | -0.05% | — |
| R&D · YoY | — | — | — | — | — | — | — | — | — |
| Per-share | |||||||||
| EPS · diluted · YoY | — | -190.12% | +124.66% | +103.70% | +150.00% | -20.00% | +4.12% | +0.61% | -0.75% |
| EPS · basic · YoY | — | -128.63% | +125.11% | +103.64% | +150.00% | -20.11% | +2.89% | +2.92% | -15.42% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $11.08B | $10.61B | $10.11B | $10.01B | $13.07B | $14.67B | $14.24B | $13.94B |
| Net debt | $10.69B | $10.35B | $9.89B | $9.93B | $12.79B | $14.44B | $14B | $13.7B |
| Net debt / EBITDA | — | — | — | — | 16.09 | 108.56 | 105.31 | 101.88 |
| Debt / equity | 2.96 | 3.98 | 3.95 | 3.96 | 5.08 | 4.45 | 4.24 | 4.30 |
| Debt / assets | +71.89% | +79.20% | +78.19% | +76.35% | +82.68% | +82.17% | +75.15% | +76.93% |
| Equity / assets | +24.25% | +19.90% | +19.79% | +19.26% | +16.27% | +18.48% | +17.74% | +17.88% |
| Coverage | ||||||||
| EBITDA / interest expense | 0.00 | 0.00 | 0.00 | 0.00 | 1.43 | 0.19 | 0.19 | 0.20 |
| Operating income / interest | 0.00 | 0.00 | 0.00 | 0.00 | 1.38 | 0.18 | 0.18 | 0.19 |
| Interest expense | $326.63M | $333.29M | $509.54M | $496.27M | $554.92M | $713.88M | $694.24M | $681.36M |
| Liquidity | ||||||||
| Current ratio | 2.32 | 2.88 | 3.98 | 2.60 | 0.07 | — | — | — |
| Quick ratio | 2.30 | 2.84 | 3.95 | 2.58 | 0.07 | — | — | — |
| Cash ratio | 0.07 | 0.06 | 0.08 | 0.02 | 0.05 | — | — | — |
| Working capital | $7.24B | $7.68B | $8.77B | $7B | -$5.64B | — | — | — |
| Working capital / revenue | +685.26% | -1848.79% | +4281.51% | +2713.25% | -686.75% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).